Show simple item record

dc.contributor.authorSwai, Hulda
dc.contributor.authorSemete, B.
dc.contributor.authorKalombo, Lonji
dc.contributor.authorChelule, P.
dc.date.accessioned2019-10-16T12:35:32Z
dc.date.available2019-10-16T12:35:32Z
dc.date.issued2008-12-18
dc.identifier.urihttps://doi.org/10.1016/j.jconrel.2008.09.032
dc.identifier.urihttp://dspace.nm-aist.ac.tz/handle/123456789/495
dc.descriptionResearch Article published by Elsevier Volume 132, Issue 3, 18 December 2008en_US
dc.description.abstractAn effective therapeutic regimen is available for the treatment of tuberculosis (TB), however in developing countries; patient non-compliance due to high dose frequency and the lengthy duration of treatment, presents a major challenge, thus resulting in treatment failure. To address this challenge, the project seeks to develop a nano-drug delivery system whereby anti-TB drugs can be administered in a single dose that maintains an active level of the drug for at least one week.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectResearch Subject Categories::NATURAL SCIENCESen_US
dc.titlePotential of treating tuberculosis with a polymeric nano-drug delivery systemen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record